Therapeutic failure in scabies : An observational study;Gales en échec de traitement : étude observationnelle

Annales de Dermatologie et de Venereologie

Volumn 143, Issue 1, 2016, Pages 9-15

  De Sainte Marie, B ^a   Mallet, S ^a   Gaudy Marqueste, C ^a   Baumstarck, K ^a,b   Bentaleb, N ^a   Loundou, A ^a,b   Hesse, S ^a   Monestier, S ^a   Grob, J J ^a   Richard, M A ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Anti scabiestreatment; Ivermectin; Scabicid; Scabies; Therapeutic failure

Indexed keywords

ANTIPARASITIC AGENT; BENZYL BENZOATE; ESDEPALLETHRIN; IVERMECTIN; PERMETHRIN; PIPERONYL BUTOXIDE; UNCLASSIFIED DRUG; ALLETHRIN; BENZOIC ACID DERIVATIVE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONSULTATION; CROSS-SECTIONAL STUDY; DERMATOLOGIST; DESCRIPTIVE RESEARCH; DRUG TREATMENT FAILURE; GENERAL PRACTITIONER; HAND WASHING; HEALTH CARE COST; HUMAN; OBSERVATIONAL STUDY; PRESCRIPTION; SCABIES; AGED; DERMATOLOGY; FEMALE; FRANCE; GENERAL PRACTICE; HAND DISINFECTION; INFANT; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT FAILURE; WASTE MANAGEMENT;

ADMINISTRATION, ORAL; ADULT; AGED; ALLETHRIN; ANTIPARASITIC AGENTS; BENZOATES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DECONTAMINATION; DERMATOLOGY; FEMALE; FRANCE; GENERAL PRACTICE; HAND DISINFECTION; HUMANS; INFANT; IVERMECTIN; MALE; MIDDLE AGED; PERMETHRIN; SCABIES; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT FAILURE;

EID: 84958102155     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2015.10.588     Document Type: Article

References (16)

1. Bitar D, Thiolet JM, Haeghebaert S, Castor C, Poujol I, CoignardB, et al. La gale en France entre 1999 et 2010 : augmentationde l'incidence et implications en santé publique. Ann DermatolVenereol 2012;139:428-34.
2. http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Rupture-de-stock-en-Ascabiol-conduite-a-tenir-Point-d-information.
3. Hérissé AL, Chiaverini C, Hubich T, Tran A, Haas H, Del GiudiceP, et al. Causes d'échec thérapeutique de la gale en pédiatrie.Communication orale. Seánce de la Société francąise de der-matologie. Seánce de dermatologie pédiatrique du 16 janvier2014. Paris; 2014.
4. Mellanby K. The transmission of scabies. BMJ 1941;2:405-6.
5. Recommandations relatives à la conduite à tenir devant unou plusieurs cas de, gale. Haut Conseil de Santé Publique;2012.
6. Usha V, Gopalakrishnan Nair TV. A comparative study of oralivermectin and topical permethrin cream in the treatment ofscabies. J Am Acad Dermatol 2000;42:236-40.
7. Sharma R, Singal A. Topical permethrin and oral ivermectinin the management of scabies: a prospective, randomized,double blind, controlled study. Ind J Dermatol Venereol Leprol2011;77:581-6.
8. Currie BJ, Harumal P, McKinnon M, Walton SF. First documenta-tion of in vivo and in vitro ivermectine resistance in Sarcoptesscabiei. Clin Infect Dis 2004;39:e8-12.
9. Glaziou JP, Cartel JL, Alzieu P, Briot C, Moulia-Pelat JP, MartinPM. Comparison of ivermectin and benzyl benzoate for treat-ment of scabies. Trop Med Parasitol 1993;44:331-2.
10. Brooks PA, Grace RF. Ivermectin is better than benzyl benzoatefor childhood scabies in developing countries. J Paediatr ChildHealth 2002;38:401-4.
11. Ly F, Caumes E, Ndaw CA, Ndiaye B, Mahé A. Ivermectin versusbenzyl benzoate applied once or twice to treat human scabiesin Dakar, Senegal: a randomized controlled trial. Bull WorldHealth Organ 2009;87:424-30.
12. Nnoruka EN, Agu CE. Successful treatment of scabies with oralivermectin in Nigeria. Trop Doct 2001;31:15-8.
13. Bachewar NP, Thawani VR, Mali SN, Gharpure KJ, Shingade VP,Dakhale GN. Comparison of safety, efficacy, and cost effec-tiveness of benzyl benzoate, permethrin, and ivermectin inpatients of scabies. Indian J Pharmacol 2009;41:9-14.
14. Amerio P, Capizzi R, Milani M. Efficacy and tolerability ofnatural synergised pyrethrins in a new thermo labile foamformulation in topical treatment of scabies: a prospective,randomised, investigator-blinded, comparative trial vs. perme-thrin cream. Eur J Dermatol 2003;13:69-71.
15. Biele M, Campori G, Colombo R, De Giorgio G, Frascione P, SaliR, et al. Efficacy and tolerability of a new synergized pyrethrinsthermofobic foam in comparison with benzyl benzoate in thetreatment of scabies in convicts: the ISAC study (Studio Dellascabbia in ambiente carcerario). J Eur Acad Dermatol Venereol2006;20:717-20.
16. Strong M, Johnstone P. Interventions for treating sca-bies. Cochrane Database Syst Rev 2007;3:CD000320 [Review].